307 related articles for article (PubMed ID: 21567076)
1. Insulin-dependent diabetes mellitus decreases osteoblastogenesis associated with the inhibition of Wnt signaling through increased expression of Sost and Dkk1 and inhibition of Akt activation.
Hie M; Iitsuka N; Otsuka T; Tsukamoto I
Int J Mol Med; 2011 Sep; 28(3):455-62. PubMed ID: 21567076
[TBL] [Abstract][Full Text] [Related]
2. Zinc supplementation inhibits the increase in osteoclastogenesis and decrease in osteoblastogenesis in streptozotocin-induced diabetic rats.
Iitsuka N; Hie M; Tsukamoto I
Eur J Pharmacol; 2013 Aug; 714(1-3):41-7. PubMed ID: 23735664
[TBL] [Abstract][Full Text] [Related]
3. Increased expression of the receptor for activation of NF-kappaB and decreased runt-related transcription factor 2 expression in bone of rats with streptozotocin-induced diabetes.
Hie M; Tsukamoto I
Int J Mol Med; 2010 Oct; 26(4):611-8. PubMed ID: 20818503
[TBL] [Abstract][Full Text] [Related]
4. Zinc deficiency decreases osteoblasts and osteoclasts associated with the reduced expression of Runx2 and RANK.
Hie M; Iitsuka N; Otsuka T; Nakanishi A; Tsukamoto I
Bone; 2011 Dec; 49(6):1152-9. PubMed ID: 21893222
[TBL] [Abstract][Full Text] [Related]
5. Fluoride promotes osteoblastic differentiation through canonical Wnt/β-catenin signaling pathway.
Pan L; Shi X; Liu S; Guo X; Zhao M; Cai R; Sun G
Toxicol Lett; 2014 Feb; 225(1):34-42. PubMed ID: 24300170
[TBL] [Abstract][Full Text] [Related]
6. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
7. BMP9 directly induces rapid GSK3-β phosphorylation in a Wnt-independent manner through class I PI3K-Akt axis in osteoblasts.
Eiraku N; Chiba N; Nakamura T; Amir MS; Seong CH; Ohnishi T; Kusuyama J; Noguchi K; Matsuguchi T
FASEB J; 2019 Nov; 33(11):12124-12134. PubMed ID: 31365832
[TBL] [Abstract][Full Text] [Related]
8. Increased cathepsin K and tartrate-resistant acid phosphatase expression in bone of streptozotocin-induced diabetic rats.
Hie M; Shimono M; Fujii K; Tsukamoto I
Bone; 2007 Dec; 41(6):1045-50. PubMed ID: 17916452
[TBL] [Abstract][Full Text] [Related]
9. GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.
Amirhosseini M; Madsen RV; Escott KJ; Bostrom MP; Ross FP; Fahlgren A
J Cell Physiol; 2018 Mar; 233(3):2398-2408. PubMed ID: 28731198
[TBL] [Abstract][Full Text] [Related]
10. FHL2 mediates dexamethasone-induced mesenchymal cell differentiation into osteoblasts by activating Wnt/beta-catenin signaling-dependent Runx2 expression.
Hamidouche Z; Haÿ E; Vaudin P; Charbord P; Schüle R; Marie PJ; Fromigué O
FASEB J; 2008 Nov; 22(11):3813-22. PubMed ID: 18653765
[TBL] [Abstract][Full Text] [Related]
11. Direct inhibition of osteoblastic Wnt pathway by fibroblast growth factor 23 contributes to bone loss in chronic kidney disease.
Carrillo-López N; Panizo S; Alonso-Montes C; Román-García P; Rodríguez I; Martínez-Salgado C; Dusso AS; Naves M; Cannata-Andía JB
Kidney Int; 2016 Jul; 90(1):77-89. PubMed ID: 27165819
[TBL] [Abstract][Full Text] [Related]
12. Exendin-4 exerts osteogenic actions in insulin-resistant and type 2 diabetic states.
Nuche-Berenguer B; Moreno P; Portal-Nuñez S; Dapía S; Esbrit P; Villanueva-Peñacarrillo ML
Regul Pept; 2010 Jan; 159(1-3):61-6. PubMed ID: 19586609
[TBL] [Abstract][Full Text] [Related]
13. Administration of zinc inhibits osteoclastogenesis through the suppression of RANK expression in bone.
Hie M; Tsukamoto I
Eur J Pharmacol; 2011 Oct; 668(1-2):140-6. PubMed ID: 21806983
[TBL] [Abstract][Full Text] [Related]
14. DEC1 deficiency results in accelerated osteopenia through enhanced DKK1 activity and attenuated PI3KCA/Akt/GSK3β signaling.
He S; Guan Y; Wu Y; Zhu L; Yan B; Honda H; Yang J; Liu W
Metabolism; 2021 May; 118():154730. PubMed ID: 33607194
[TBL] [Abstract][Full Text] [Related]
15. Wnt inhibitors Dkk1 and Sost are downstream targets of BMP signaling through the type IA receptor (BMPRIA) in osteoblasts.
Kamiya N; Kobayashi T; Mochida Y; Yu PB; Yamauchi M; Kronenberg HM; Mishina Y
J Bone Miner Res; 2010 Feb; 25(2):200-10. PubMed ID: 19874086
[TBL] [Abstract][Full Text] [Related]
16. A phytoestrogen diarylheptanoid mediates estrogen receptor/Akt/glycogen synthase kinase 3β protein-dependent activation of the Wnt/β-catenin signaling pathway.
Bhukhai K; Suksen K; Bhummaphan N; Janjorn K; Thongon N; Tantikanlayaporn D; Piyachaturawat P; Suksamrarn A; Chairoungdua A
J Biol Chem; 2012 Oct; 287(43):36168-78. PubMed ID: 22936801
[TBL] [Abstract][Full Text] [Related]
17. SiJunZi decoction ameliorates bone quality and redox homeostasis and regulates advanced glycation end products/receptor for advanced glycation end products and WNT/β-catenin signaling pathways in diabetic mice.
Dai X; Liu Y; Liu T; Zhang Y; Wang S; Xu T; Yin J; Shi H; Ye Z; Zhu R; Gao J; Dong G; Zhao D; Gao S; Wang X; Prentki M; Brὂmme D; Wang L; Zhang D
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117167. PubMed ID: 37716489
[TBL] [Abstract][Full Text] [Related]
18. Influence of an LRP5 cytoplasmic SNP on Wnt signaling and osteoblastic differentiation.
Guo J; Cooper LF
Bone; 2007 Jan; 40(1):57-67. PubMed ID: 16956801
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of type 1 diabetes mellitus and subsequent osteoblastic β-catenin activation on trabecular and cortical bone in a mouse model.
Chen S; Liu D; He S; Yang L; Bao Q; Qin H; Liu H; Zhao Y; Zong Z
Exp Mol Med; 2018 Dec; 50(12):1-14. PubMed ID: 30518745
[TBL] [Abstract][Full Text] [Related]
20. Runx2 alleviates high glucose-suppressed osteogenic differentiation via PI3K/AKT/GSK3β/β-catenin pathway.
Chen Y; Hu Y; Yang L; Zhou J; Tang Y; Zheng L; Qin P
Cell Biol Int; 2017 Aug; 41(8):822-832. PubMed ID: 28462510
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
